1Lociulli A, Oneto R, Bacigalupo A,et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).Haematologica. , 2007 ; 92( 1 ) : 11-18.
2Maury S, Balere-Apperl ML, Chir Z, et al. Unrelated stem cell transplantation for severe acquired aplastie anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologiea, 2007 ; 92 ( 5 ) : 589 -596.
3Stem M, Passweg JR, Locasciulli A, et al. Influence of denor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation, 2006 ; 82 ( 2 ) : 218-226.
5Schrezenmeicr H, Passweg JR, Marsh JC, et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood, 2007; 110 ( 4 ) : 1397-1400.
6Watanabe T, Kajiume T, Abe T, et al. Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies from HLA-matched siblings. Med Pediatr Oncol,2003; 34(3) :171- 176.
7Ohga S, Ichino K, Goto K, et al. Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. Pediatr Transplantation, 2006 ; 10 (4) :497-500.
8Min CK, Kim DW, Lee JW, et al. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Haematologica, 2001 ; 86(3) :303-310.
9Kennedy-Nasser AA, Leung KS, Mahajan A, et al. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastie anemia. Biol Blood Marrow Transplant,2006; 12(12) :1277-1284.
10Kang H J, Shin HY, Choi HS,et al. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant, 2004; 34(11 ) :939-943.
4Bucker CD, Clift RA, Sanders JE, et al. ABO-incompatible marrow transplants. Transplantation, 1978 , 26:233 - 238
5Lee JH, Lee KH, Kim S, et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO- incompatible allogeneic bone marrow transplatation. Bone Marrow Transplant, 2000,25 : 179 - 184
6Bensinger WI, Buckner CD, Thomas ED, et al. ABO-incompatible marrow transplantats. Transplantation, 1982; 33:427 -429
7Rowley SD, Liang PS, Ulz L, et al. Transplantation of ABO-incompatible bone marrow peripheral blood stem cell components. Bone marrow Transplant,2000,26:749 - 757
8Klumpp TR, Herman JH, Ulicny J, et al. Lack of effect of donorrecipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 2006;38:615 -620
9Mueller RJ, Stussi G, Odermatt B, et al. Major ABO-incompatible hematooietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Xenotransplantation, 2006; 13 : 126 - 132
10Stussi G, Huggel K, Lutz HU, et al. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol, 2005; 130:954 - 963
